Project Details
Description
International, multi-center, double blind 9-month follow-up extension study assessing the long term safety and tolerability of PXT3003 in patients with Charcot-Marie-Tooth Disease type 1A
Status | Active |
---|---|
Effective start/end date | 1/15/17 → 12/31/24 |
Funding
- PHARNEXT
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.